Literature DB >> 10411039

Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995.

J M McKiernan1, E T Goluboff, G L Liberson, R Golden, H Fisch.   

Abstract

PURPOSE: Recent epidemiological studies have demonstrated an increasing incidence of testicular cancer in white men which appears to be correlated with the period of birth. Because this birth cohort phenomenon can explain etiological factors in testicular cancer, we determine whether this trend is present throughout the United States based on an analysis of testicular cancer incidence by birth cohort.
MATERIALS AND METHODS: Testicular cancer incidence was obtained from the National Cancer Institute Surveillance, Epidemiology and End Results database from 1973 to 1995. Numbers of cases were extracted and grouped by 5-year birth cohorts for all testicular germ cell neoplasms. Poisson regression analysis with variables of age, time of diagnosis and birth cohort were used to determine relative risk. Poisson models were compared using computer log linear model software.
RESULTS: Between 1973 and 1995 the incidence of testicular cancer in the United States increased 51% (3.61 to 5.44/100,000). Analysis of Poisson models revealed that birth cohort was strongly associated with relative risk of testicular cancer (p = 0.001). In addition, peak age at diagnosis decreased for each successive birth cohort.
CONCLUSIONS: The overall incidence of testicular cancer in white men and the relative risk of testicular cancer have been increasing in the United States. This trend is strongly associated with birth cohort in concordance with previously reported European data. Moreover, testicular cancer is being diagnosed at a younger age as evidenced by a shift to the left in the age of peak incidence. These unique epidemiological patterns offer a basis for analysis of potential etiological factors.

Entities:  

Mesh:

Year:  1999        PMID: 10411039

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

Review 1.  Environment and health: 6. Endocrine disruption and potential human health implications.

Authors:  G M Solomon; T Schettler
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

Review 2.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 3.  Familial testicular germ cell tumours.

Authors:  Christian P Kratz; Phuong L Mai; Mark H Greene
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

Review 4.  Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.

Authors:  Mark H Greene; Christian P Kratz; Phuong L Mai; Christine Mueller; June A Peters; Gennady Bratslavsky; Alex Ling; Peter M Choyke; Ahalya Premkumar; Janet Bracci; Rissah J Watkins; Mary Lou McMaster; Larissa A Korde
Journal:  Endocr Relat Cancer       Date:  2010-03-08       Impact factor: 5.678

5.  Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009.

Authors:  Manas Nigam; Briseis Aschebrook-Kilfoy; Sergey Shikanov; Scott Eggener
Journal:  World J Urol       Date:  2014-07-17       Impact factor: 4.226

Review 6.  Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Authors:  Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

7.  Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm?

Authors:  L Holmes; C Escalante; O Garrison; B X Foldi; G O Ogungbade; E J Essien; D Ward
Journal:  Public Health       Date:  2008-06-13       Impact factor: 2.427

8.  Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer.

Authors:  Hua-Yin Yu; Nathanael D Hevelone; Sunil Patel; Stuart R Lipsitz; Jim C Hu
Journal:  Adv Urol       Date:  2012-04-09

9.  Cordycepin Induced MA-10 Mouse Leydig Tumor Cell Apoptosis through Caspase-9 Pathway.

Authors:  Chun-Yi Jen; Chun-Yu Lin; Bu-Miin Huang; Sew-Fen Leu
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-18       Impact factor: 2.629

10.  An approach to assessment of endocrine disruption in the National Children's Study.

Authors:  Matthew P Longnecker; David C Bellinger; David Crews; Brenda Eskenazi; Ellen K Silbergeld; Tracey J Woodruff; Ezra S Susser
Journal:  Environ Health Perspect       Date:  2003-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.